Morphometry and hemodynamics of coronary artery aneurysms caused by atherosclerosis

Tingting Fan1, Zhen Zhou2, Wenxuan Fang1

  • 1Department of Mechanics and Engineering Science, College of Engineering, Peking University, Beijing, China; PKU-HKUST Shenzhen-Hongkong Institution, Shenzhen, China.

Atherosclerosis
|April 2, 2019
PubMed

Insights

Coronary artery aneurysms (CAAs) are linked to atherosclerosis. A new two-step analysis identifies coronary artery bifurcations and aneurysm shape as key risk factors for CAA development and associated ischemia.

Area of Science:

  • Cardiovascular research
  • Medical imaging analysis
  • Biomechanical engineering

Background:

  • Atherosclerosis is the primary cause of coronary artery aneurysms (CAAs), posing challenges in preventing their development.
  • Understanding the morphometric and hemodynamic factors contributing to CAA is crucial for risk assessment.

Purpose of the Study:

  • To conduct morphometric and hemodynamic analyses of epicardial coronary arteries in patients with atherosclerosis-induced CAAs.
  • To develop and validate a novel two-step analysis method for enhanced CAA risk stratification.

Main Methods:

  • Reconstruction of epicardial coronary arterial trees from 61 patients.
  • Determination of morphometric and hemodynamic parameters using computed flow fields.
  • Implementation of a two-step analysis prioritizing coronary artery bifurcation and aneurysm shape index (L/W).

Main Results:

  • Coronary artery bifurcations are identified as a major risk factor for CAA, followed by a high aneurysm shape index (L/W).
  • Patients with CAAs covering bifurcations exhibit a higher incidence of myocardial ischemia (71% vs. 43% for L/W ≥ 2) compared to those with CAAs in single vessels.
  • CAAs with L/W ≥ 2 at bifurcations present the most adverse hemodynamic environment.

Conclusions:

  • Morphometric and hemodynamic findings support the proposed two-step analysis method for CAA risk assessment.
  • This approach offers a clinical rationale for noninvasive evaluation of coronary artery aneurysms.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
958
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
409
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
238
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
622
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
358
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
363